These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28088639)

  • 21. Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR).
    Mitsutake H; Ribeiro LNM; Rodrigues da Silva GH; Castro SR; de Paula E; Poppi RJ; Breitkreitz MC
    Eur J Pharm Sci; 2019 Jul; 135():51-59. PubMed ID: 31071439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid.
    Correia M; Michel V; Osório H; El Ghachi M; Bonis M; Boneca IG; De Reuse H; Matos AA; Lenormand P; Seruca R; Figueiredo C; Machado JC; Touati E
    PLoS One; 2013; 8(4):e60657. PubMed ID: 23577140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solidification of Nanostructured Lipid Carriers Loaded Testosterone Undecanoate: In Vivo and In Vitro Study.
    Hua Y; Li W; Cheng Z; Zhao Z; Yin X; Li Y; Sun J; Gao J; Zhang H; Zheng A
    Drug Res (Stuttg); 2018 Aug; 68(8):457-464. PubMed ID: 29589341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil, and polysorbate 80.
    How CW; Rasedee A; Abbasalipourkabir R
    IEEE Trans Nanobioscience; 2013 Jun; 12(2):72-8. PubMed ID: 23268387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
    Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
    Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of Deep Sea Fish Oil-Based Nanostructured Lipid Carriers with Enhanced Cellular Uptake.
    Zhu QY; Guissi F; Yang RY; Wang Q; Wang K; Chen D; Han ZH; Ma Y; Zhang M; Gu YQ
    J Nanosci Nanotechnol; 2015 Dec; 15(12):9539-47. PubMed ID: 26682376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Charge, Size and Protein Corona Modulate the Specific Activity of Nanostructured Lipid Carriers (NLC) against
    Chitas R; Nunes C; Reis S; Parreira P; Martins MCL
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.
    Mussi SV; Sawant R; Perche F; Oliveira MC; Azevedo RB; Ferreira LA; Torchilin VP
    Pharm Res; 2014 Aug; 31(8):1882-92. PubMed ID: 24522814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Kasongo KW; Pardeike J; Müller RH; Walker RB
    J Pharm Sci; 2011 Dec; 100(12):5185-96. PubMed ID: 22020815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Silver(I) Coordination Compound Loaded into Polymeric Nanoparticles as a Strategy to Improve
    Almeida Furquim de Camargo B; Soares Silva DE; Noronha da Silva A; Campos DL; Machado Ribeiro TR; Mieli MJ; Borges Teixeira Zanatta M; Bento da Silva P; Pavan FR; Gallina Moreira C; Resende FA; Menegário AA; Chorilli M; Vieira de Godoy Netto A; Bauab TM
    Mol Pharm; 2020 Jul; 17(7):2287-2298. PubMed ID: 32515970
    [No Abstract]   [Full Text] [Related]  

  • 33. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
    Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
    Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of three different fish oil formulations on Helicobacter pylori growth and viability: in vitro study.
    Drago L; Mombelli B; Ciardo G; De Vecchi E; Gismondo MR
    J Chemother; 1999 Jun; 11(3):207-10. PubMed ID: 10435683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
    Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
    Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
    Kovács A; Berkó S; Csányi E; Csóka I
    Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.
    Barbosa JP; Neves AR; Silva AM; Barbosa MA; Reis MS; Santos SG
    Int J Nanomedicine; 2016; 11():3501-16. PubMed ID: 27555771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.
    Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V
    Colloids Surf B Biointerfaces; 2014 Nov; 123():610-5. PubMed ID: 25454755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Narrow-spectrum inhibitors targeting an alternative menaquinone biosynthetic pathway of Helicobacter pylori.
    Yamamoto T; Matsui H; Yamaji K; Takahashi T; Øverby A; Nakamura M; Matsumoto A; Nonaka K; Sunazuka T; Ōmura S; Nakano H
    J Infect Chemother; 2016 Sep; 22(9):587-92. PubMed ID: 27346378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
    Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
    J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.